Maximising therapeutic options for HIV infection

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1351, 2002-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic options for HIV-associated lymphomas

By Spina Michele   Gloghini Annunziata   Tirelli Umberto   Carbone Antonino  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 15, 2010-10 ,pp. : 2471-2481

Informa Healthcare

Access to resources Recommend Favorite

Systemic immune activation in HIV and potential therapeutic options

By Sinha Bhaswati   Rubens Muni  

Immunopharmacology and Immunotoxicology, Vol. 36, Iss. 2, 2014-04 ,pp. : 89-95

Informa Healthcare

Access to resources Recommend Favorite

Tuberculosis and HIV Co-Infection: A Practical Therapeutic Approach

By Breen Ronan A.M.   Swaden Leonie   Ballinger Jayne   Lipman Marc C.I.  

Drugs, Vol. 66, Iss. 18, 2006-01 ,pp. : 2299-2308

Adis International

Access to resources Recommend Favorite

Nelfinavir: A Review of its Therapeutic Efficacy in HIV Infection

By Jarvis B.   Faulds D.  

Drugs, Vol. 56, Iss. 1, 1998-07 ,pp. : 147-167

Adis International

Access to resources Recommend Favorite

Ubiquitin ligases as therapeutic targets in HIV-1 infection

By Votteler Jörg   Schubert Ulrich  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 131-143

Informa Healthcare

Access to resources Recommend Favorite